Home > Insider Trading > Filing (0001104659-16-139272)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1638287	Gemphire Therapeutics Inc.	GEMP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1571997	Ph.d. R. Steven Gullans	43334 Seven Mile Road Suite 1000 Northville MI 48167		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-08-10	306,025	$6.71	306,025	No	4	C	Indirect	Held by Excel Venture Fund II, L.P.
Common Stock	Acquisiton	2016-08-10	500,000	$10.00	806,025	No	4	P	Indirect	Held by Excel Venture Fund II, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	Held by Excel Venture Fund II, L.P.
No	4	P	Indirect	Held by Excel Venture Fund II, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	8% Convertible Subordinated Promissory Note	Disposition	2016-08-10	0	$0.00	306,025	$6.71

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

The reporting person, as the Manager of Excel Venture Fund II, L.P., beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The note was issued in the original principal amount of $2,000,000. The outstanding principal and $52,164 of accrued interest on the note automatically converted into shares of Common Stock immediately prior to the closing of the Company's initial public offering.